
DSP Healthcare Fund (G)
Equity · Sectoral
16.76%
Last 1 year
- Exit Load
- 0.50%
- Expense Ratio
- 2.05%
- Min. AmountMin. SIP Amount
- ₹100
- Min. Lump SumMin. Lump sum
- ₹100
Historical View
Return Calculator
- Invested Amount
- ₹9,00,000
- Calculated AmountCurrent Value
- ₹12,25,619
- IRR
- 19.296%
- Absolute Gain
- +₹3,25,619 (+36.2%)
Returns & Rankings
Category: Equity Sectoral


63 ProductsEquity Sectoral Funds


63 ProductsWealthy Score
Return Score rates how well the fund has rewarded investors over time, comparing its returns across periods with other funds in its category.
- 1Y Returns
- 16.8%
- 3Y Returns
- 19.3%
- 5Y Returns
- 15.2%
- Alpha
- 13.54
Holding Analysis
Equity/Debt/Cash Split
- Equity88.2%
- Debt11.8%
Market Cap Weightage
- Mid Cap36.3%
- Small Cap32.3%
- Large Cap19.6%
- Others11.8%
Sector allocation
- Healthcare87.2%
- Debt11.8%
- Financials1%
Top 10 HoldingsTop Holdings
| Stocks | Sector | Percentage |
|---|---|---|
| Apollo Hospitals | Healthcare | 7.89% |
| Ipca Labs. | Pharmaceuticals | 7.49% |
| Cipla | Pharmaceuticals | 7.4% |
| Sun Pharma.Inds. | Pharmaceuticals | 7.32% |
| Gland Pharma | Pharmaceuticals | 6.61% |
| Sai Life | Pharmaceuticals | 6.17% |
| Globus Medical Inc | Debt Others | 5.36% |
| Alkem Lab | Pharmaceuticals | 4.73% |
| Divi's Lab. | Pharmaceuticals | 4.41% |
| Cohance Life | Pharmaceuticals | 3.82% |
- 7.89%
Apollo Hospitals
Healthcare
- 7.49%
Ipca Labs.
Pharmaceuticals
- 7.4%
Cipla
Pharmaceuticals
- 7.32%
Sun Pharma.Inds.
Pharmaceuticals
- 6.61%
Gland Pharma
Pharmaceuticals
Top Funds in the Category
| Fund Name | Rating | Category | 1Y | 3Y |
|---|---|---|---|---|
| — | Equity | 16.23% | 29.6% | |
| — | Equity | 28.41% | 28.89% | |
| — | Equity | 23.71% | 23.26% | |
| — | Equity | 20.06% | 21.85% | |
| — | Equity | 24.28% | 21.75% |
Peer Comparison
DSP Healthcare Fund (G)
- 1 Y Return
- 16.76%
- 3 Y Return
- 19.30%
- 5 Y Return
- 15.21%
Nifty 50
- 1 Y Return
- -2.32%
- 3 Y Return
- 9.41%
- 5 Y Return
- 8.00%
Investment Objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there can be no assurance that the investment objective of the scheme will be realized.
Fund Management

Chirag Dagli
Over 20 years of experience as detailed under: From November 02, 2020 to till date: Equity Research in Healthcare - DSPIM From November 2012 to October 2020: Senior Equity Analyst -HDFC AMC Ltd. From August 2012 to October 2012: Senior Manager - Fund Management - Aviva Life Insurance From October 2010 to August 2012: Vice President - ICICI Securities From March 2009 to October 2010: Vice President - Research - Infinity.Com Financial Securities Ltd (Pioneer Invest Corp) From April 2008 to February 2009: Asst. Vice President - Global Markets - Deutsche Equities India Private Limited From October 2003 to April 2008: Research Analyst - Citigroup Global Markets India Private Limited From May 2001 to September 2003: Associate - Equity Research - ICICI Securities
Riskometer
- Risk Score
- 6
- Risk Level
- Very High
Advanced Ratios
- AlphaReturn earned over the benchmark after adjusting for risk. Higher is better.
- 13.54
- BetaHow much the fund moves with the market. Above 1 means more volatile than the market.
- 0.68
- SRSharpe Ratio: return earned per unit of total risk taken. Higher is better.
- 0.90
- SDStandard Deviation: how much returns swing around their average. Lower means steadier returns.
- 15.19
- TRTreynor Ratio: return earned per unit of market risk (beta). Higher is better.
- 0.08
- P/EPrice to Earnings of the stocks the fund holds. Higher means a pricier portfolio.
- 41.83
Tax Implication
STCG Tax: 20% if redeemed before 1 Year. LTCG Tax: 12.5% exceeding Rs. 1,25,000/- post 1 Year
FAQs
DSP Healthcare Fund – Regular Plan - Growth was launched 8 years ago and has delivered annualised returns (CAGR) of 21.29% since inception. Here is how it compares with the category average:
Period Fund Category average 1 Year 16.76% 6.93% 3 Years 19.30% 14.57% 5 Years 15.21% 11.55% Since Inception 21.29% Returns as on 18 Nov 2026. 1-year returns are absolute; returns above 1 year are CAGR. Past performance may or may not be sustained in future.
The expense ratio of DSP Healthcare Fund – Regular Plan - Growth is 2.05%. This is the annual fee for managing and operating the fund. It is adjusted in the daily NAV, so the returns you see are already net of this cost.
DSP Healthcare Fund is rated Very High risk on the SEBI riskometer. The riskometer has six levels, from Low to Very High, and fund houses review it every month.
You can start an SIP in DSP Healthcare Fund with ₹100 a month, or invest a lump sum of ₹100. Additional investments start at ₹100.
DSP Healthcare Fund charges an exit load of 0.5% if redeemed within 1 month of investment. The exit load is deducted from the redemption amount.
No, DSP Healthcare Fund has no lock-in period, so you can redeem anytime. An exit load may apply on early redemption.
DSP Healthcare Fund manages assets (AUM) of approximately ₹3,727 Cr.
As on 31 Oct 2026, DSP Healthcare Fund holds 35 securities. These are its top 10 holdings:
Company % of portfolio Apollo Hospitals 7.89% Ipca Labs. 7.49% Cipla 7.40% Sun Pharma.Inds. 7.32% Gland Pharma 6.61% Sai Life 6.17% Globus Medical Inc 5.36% Alkem Lab 4.73% Divi's Lab. 4.41% Cohance Life 3.82% As on 31 Oct 2026, these are the fund's largest sector allocations:
Sector % of portfolio Healthcare 87.21% Debt 11.77% Financials 1.02% If you invested through a Wealthy partner, you can place a redemption request in the Wealthy app, or ask your partner to do it for you. If you invested elsewhere, you can redeem through the DSP Mutual Fund website, MF Central or CAMS. The money is credited to your registered bank account, usually within a few working days. Exit load and capital gains tax may apply.












